Interaction between the Cdk2/Cyclin A complex and a small molecule derived from the prb2/p130 spacer domain: A theoretical model

Antonio Giordano, Emanuele Bellacchio, Luigi Bagella, Marco G. Paggi

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Retinoblastoma (RB) family proteins pRb, p107 and pRb2/p130 are important cellular factors which play a well-recognized role as tumor and growth suppressors. These proteins are actively involved in the negative control of the cell cycle and their function is modulated via complex homeostatic processes, most of them involving post-translational regulation of their phosphorylation status. Interestingly, the family members p107 and pRb2/p130 share the ability to physically interact and inhibit the kinase activity of the Cdk2/Cyclin A and Cdk2/Cyclin E complexes. Regarding pRb2/p130, its inhibitory effect on Cdk2/Cyclin A activity has been attributed to the "spacer" region. Recently, a 39 aa-long pRb2/p130 spacer-derived peptide (Spa310, aa 641-679) was selected as the sequence responsible for Cdk2/Cyclin A inhibition. Following the identification of this active sequence, here we propose a computer-generated three-dimensional model of the interaction between the Cdk2/Cyclin A complex and the N-terminal nine-amino acid sequence of the Spa310 peptide. We believe this model to be useful for the rational development of peptide or peptidomimetic kinase inhibitors for negative cell cycle modulation in cancer cells.

Original languageEnglish
Pages (from-to)2591-2593
Number of pages3
JournalCell Cycle
Volume6
Issue number21
Publication statusPublished - Nov 1 2007

Fingerprint

Cyclin A
Theoretical Models
Molecules
Cells
Peptides
Phosphotransferases
Peptidomimetics
Cyclin E
Retinoblastoma Protein
Phosphorylation
Aptitude
Cell Cycle Checkpoints
Tumors
Amino Acid Sequence
Neoplasms
Cell Cycle
Proteins
Modulation
Amino Acids
Growth

Keywords

  • Cancer therapy
  • cdk2
  • Cell cycle
  • Cyclin A
  • Kinase inhibitors
  • pRb2/p130
  • Retinoblastoma family proteins
  • Small molecules

ASJC Scopus subject areas

  • Cell Biology
  • Biochemistry
  • Molecular Biology

Cite this

Interaction between the Cdk2/Cyclin A complex and a small molecule derived from the prb2/p130 spacer domain : A theoretical model. / Giordano, Antonio; Bellacchio, Emanuele; Bagella, Luigi; Paggi, Marco G.

In: Cell Cycle, Vol. 6, No. 21, 01.11.2007, p. 2591-2593.

Research output: Contribution to journalArticle

@article{8e1b623ac1c643d2a33c0b3afa0a3685,
title = "Interaction between the Cdk2/Cyclin A complex and a small molecule derived from the prb2/p130 spacer domain: A theoretical model",
abstract = "Retinoblastoma (RB) family proteins pRb, p107 and pRb2/p130 are important cellular factors which play a well-recognized role as tumor and growth suppressors. These proteins are actively involved in the negative control of the cell cycle and their function is modulated via complex homeostatic processes, most of them involving post-translational regulation of their phosphorylation status. Interestingly, the family members p107 and pRb2/p130 share the ability to physically interact and inhibit the kinase activity of the Cdk2/Cyclin A and Cdk2/Cyclin E complexes. Regarding pRb2/p130, its inhibitory effect on Cdk2/Cyclin A activity has been attributed to the {"}spacer{"} region. Recently, a 39 aa-long pRb2/p130 spacer-derived peptide (Spa310, aa 641-679) was selected as the sequence responsible for Cdk2/Cyclin A inhibition. Following the identification of this active sequence, here we propose a computer-generated three-dimensional model of the interaction between the Cdk2/Cyclin A complex and the N-terminal nine-amino acid sequence of the Spa310 peptide. We believe this model to be useful for the rational development of peptide or peptidomimetic kinase inhibitors for negative cell cycle modulation in cancer cells.",
keywords = "Cancer therapy, cdk2, Cell cycle, Cyclin A, Kinase inhibitors, pRb2/p130, Retinoblastoma family proteins, Small molecules",
author = "Antonio Giordano and Emanuele Bellacchio and Luigi Bagella and Paggi, {Marco G.}",
year = "2007",
month = "11",
day = "1",
language = "English",
volume = "6",
pages = "2591--2593",
journal = "Cell Cycle",
issn = "1538-4101",
publisher = "Landes Bioscience",
number = "21",

}

TY - JOUR

T1 - Interaction between the Cdk2/Cyclin A complex and a small molecule derived from the prb2/p130 spacer domain

T2 - A theoretical model

AU - Giordano, Antonio

AU - Bellacchio, Emanuele

AU - Bagella, Luigi

AU - Paggi, Marco G.

PY - 2007/11/1

Y1 - 2007/11/1

N2 - Retinoblastoma (RB) family proteins pRb, p107 and pRb2/p130 are important cellular factors which play a well-recognized role as tumor and growth suppressors. These proteins are actively involved in the negative control of the cell cycle and their function is modulated via complex homeostatic processes, most of them involving post-translational regulation of their phosphorylation status. Interestingly, the family members p107 and pRb2/p130 share the ability to physically interact and inhibit the kinase activity of the Cdk2/Cyclin A and Cdk2/Cyclin E complexes. Regarding pRb2/p130, its inhibitory effect on Cdk2/Cyclin A activity has been attributed to the "spacer" region. Recently, a 39 aa-long pRb2/p130 spacer-derived peptide (Spa310, aa 641-679) was selected as the sequence responsible for Cdk2/Cyclin A inhibition. Following the identification of this active sequence, here we propose a computer-generated three-dimensional model of the interaction between the Cdk2/Cyclin A complex and the N-terminal nine-amino acid sequence of the Spa310 peptide. We believe this model to be useful for the rational development of peptide or peptidomimetic kinase inhibitors for negative cell cycle modulation in cancer cells.

AB - Retinoblastoma (RB) family proteins pRb, p107 and pRb2/p130 are important cellular factors which play a well-recognized role as tumor and growth suppressors. These proteins are actively involved in the negative control of the cell cycle and their function is modulated via complex homeostatic processes, most of them involving post-translational regulation of their phosphorylation status. Interestingly, the family members p107 and pRb2/p130 share the ability to physically interact and inhibit the kinase activity of the Cdk2/Cyclin A and Cdk2/Cyclin E complexes. Regarding pRb2/p130, its inhibitory effect on Cdk2/Cyclin A activity has been attributed to the "spacer" region. Recently, a 39 aa-long pRb2/p130 spacer-derived peptide (Spa310, aa 641-679) was selected as the sequence responsible for Cdk2/Cyclin A inhibition. Following the identification of this active sequence, here we propose a computer-generated three-dimensional model of the interaction between the Cdk2/Cyclin A complex and the N-terminal nine-amino acid sequence of the Spa310 peptide. We believe this model to be useful for the rational development of peptide or peptidomimetic kinase inhibitors for negative cell cycle modulation in cancer cells.

KW - Cancer therapy

KW - cdk2

KW - Cell cycle

KW - Cyclin A

KW - Kinase inhibitors

KW - pRb2/p130

KW - Retinoblastoma family proteins

KW - Small molecules

UR - http://www.scopus.com/inward/record.url?scp=36849053959&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36849053959&partnerID=8YFLogxK

M3 - Article

C2 - 17726381

AN - SCOPUS:36849053959

VL - 6

SP - 2591

EP - 2593

JO - Cell Cycle

JF - Cell Cycle

SN - 1538-4101

IS - 21

ER -